Sort
85,873 grants matching “alzheimers”
Contribution of child development, biological aging, and beta-amyloid to cognitive function of the Louisville twins at midlife
$1,258,300Christopher Ryan Beam · University Of Southern California · R01 · FY2021 · AG
Dementia care in nursing homes: does race matter?
$1,258,255Shubing Cai · University Of Rochester · RF1 · FY2019 · AG
New Jersey Minority Aging Collaborative
$1,258,220William Tzu-Lung Hu · Rutgers Biomedical/Health Sciences-Rbhs · R24 · FY2021 · AG
Molecular motors in cell biology
$1,257,928Yale E Goldman · University Of Pennsylvania · P01 · FY2009 · GM
Stretching their Reach: Robotic Support for Older Individuals with Mild Cognitive Impairment, Early Alzheimer's Dementia, and Mobility Impairments
$1,257,898Aaron Edsinger · Hello Robot Inc · R44 · FY2024 · AG
UC Davis Alzheimer's Disease Core Center
$1,257,815Charles Decarli · University Of California At Davis · P30 · FY2009 · AG
Indiana Alzheimer Disease Center
$1,257,667Indiana Univ-Purdue Univ At Indianapolis · P30 · FY2002 · AG
Human iPSC neural spheroids to screen for compounds that block tau propagation
$1,257,528Travis Lee Stiles · Novoron Bioscience, Inc. · R44 · FY2025 · AG
[18F]NAV4694 Imaging to Identify MCI Patients at Risk for Alzheimer's Dementia
$1,257,437Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2014 · AG
A humanized monoclonal FSH antibody for Alzheimer's Disease and co-occurring health conditions in Down Syndrome
$1,257,163Ki Ann Goosens · Icahn School Of Medicine At Mount Sinai · RF1 · FY2025 · AG
CMP3: A CSF Multiple Pathophysiology Panel for Clinical Trials in Alzheimer's Disease
$1,256,900Steven E Arnold · Massachusetts General Hospital · RF1 · FY2018 · AG
Molecular Mechanisms That Control Neuronal Positioning During Development
$1,256,749Brian W. Howell · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Mechanisms by which ABCA7 activity influences Alzheimer's Disease
$1,256,699Daniel James Rader · University Of Pennsylvania · RF1 · FY2025 · AG
The influence of familial social context on risk dissemination and coping
$1,256,549Laura M Koehly · National Human Genome Research Institute · ZIA · FY2014 · HG
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild
$1,256,516Jeffrey L Ives · Acumen Pharmaceuticals, Inc. · U01 · FY2018 · AG
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease
$1,256,516Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2018 · AG
SNRP Project at Meharry Medical College
$1,256,504Hubert K. Rucker · Meharry Medical College · U54 · FY2006 · NS
Using gamification, predictive analytics, artificial intelligence, and Alexa Voice to optimize user experience for individuals living with AD/ADRD and their caregivers
$1,256,442Matthew Golden · Maphabit, Inc. · R44 · FY2022 · AG
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
$1,256,349Arkadij Elizarov · Trace-Ability, Inc. · R44 · FY2021 · AG
Mechanisms of Aging in the Olfactory System
$1,256,066Charles A Greer · Yale University · P01 · FY2008 · AG
Sex-Specific Single Cell Expression Profiles, Genetic Risk and Drug Responsiveness in Alzheimer's Disease
$1,255,679Stephen M Strittmatter · Yale University · R56 · FY2021 · AG
Sex-Specific Single Cell Expression Profiles, Genetic Risk and Drug Responsiveness in Alzheimer's Disease
$1,255,677Stephen M Strittmatter · Yale University · R56 · FY2022 · AG
Novel mechanisms of NSAID action in Alzheimer disease
$1,255,421University Of California San Diego · P01 · FY2005 · AG
Early Markers Of Alzheimer Disease
$1,255,255Susan M Resnick · Aging · Z01 · FY2007 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES
$1,255,043Scripps Research Institute · P01 · FY2002 · AG